U.S. Army Institute of Surgical Research:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:U.S. Army Institute of Surgical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11524
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
U.S. Army Institute of Surgical Research (USAISR), a subsidiary of U.S. Army, is a medical research center that offers solutions for burn, trauma, and combat casualty care from time of injury to rehabilitation. The center conducts research in the areas of dental and trauma research detachment, and joint trauma system. It provides dental and trauma research detachment in collaboration with US Navy. USAISR’s joint trauma system improves trauma care delivery and patient outcomes across the range of various solutions. The center also offers operative techniques and treatments for head and neck injuries. It serves military, academic and industrial organizations. USAISR is headquartered in San Antonio, Texas, the US.

U.S. Army Institute of Surgical Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
U.S. Army Institute of Surgical Research, Medical Devices Deals, 2012 to YTD 2018 9
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Capricor Therapeutics Enters into Agreement with US Army Institute of Surgical Research 11
Frequency Therapeutics Enters into Agreement with Harvard University and US Army Institute of Surgical Research 12
RoosterBio Enters into Partnership with United States Army Institute of Surgical Research 13
Kineta Enters into Contract with US Army Institute of Surgical Research 14
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 15
Amarantus BioScience Enters into Cooperative Research and Development Agreement with USAISR and Rutgers University 16
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 17
U.S. Army Institute of Surgical Research – Key Competitors 18
U.S. Army Institute of Surgical Research – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Key Facts 2
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
U.S. Army Institute of Surgical Research, Deals By Therapy Area, 2012 to YTD 2018 8
U.S. Army Institute of Surgical Research, Medical Devices Deals, 2012 to YTD 2018 9
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Capricor Therapeutics Enters into Agreement with US Army Institute of Surgical Research 11
Frequency Therapeutics Enters into Agreement with Harvard University and US Army Institute of Surgical Research 12
RoosterBio Enters into Partnership with United States Army Institute of Surgical Research 13
Kineta Enters into Contract with US Army Institute of Surgical Research 14
Kane Biotech Enters into Agreement with US Army Institute of Surgical Research 15
Amarantus BioScience Enters into Cooperative Research and Development Agreement with USAISR and Rutgers University 16
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 17
U.S. Army Institute of Surgical Research, Key Competitors 18

List of Figures
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
U.S. Army Institute of Surgical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
U.S. Army Institute of Surgical Research, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[U.S. Army Institute of Surgical Research:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Denali Therapeutics Inc (DNLI):製薬・医療:M&Aディール及び事業提携情報
    Summary Denali Therapeutics Inc (Denali Therapeutics) is a clinical-stage biopharmaceutical company that focuses on the development of therapeutics for the treatment of neurodegenerative diseases. The company’s proprietary drug delivery platform technologies include antibody transport vehicle and en …
  • Columbia Sportswear Company (COLM):企業の財務・戦略的SWOT分析
    Columbia Sportswear Company (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Nationwide Building Society:企業のM&A・事業提携・投資動向
    Nationwide Building Society - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nationwide Building Society Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Great Western Bancorp Inc.:企業の戦略・SWOT・財務情報
    Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    SandRidge Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary SandRidge Energy Inc (SandRidge) is an upstream energy company. It develops, explores for, and produces oil and natural gas in the Mid-Continent and Rockies regions of the US. In Mid-Continent, …
  • MSCI Inc. (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc. (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Seoul Semiconductor Co Ltd (046890):企業の財務・戦略的SWOT分析
    Summary Seoul Semiconductor Co Ltd (Seoul Semiconductor) is an electronic device manufacturing company that manufactures LED devices. The company provides products such as Acrich series, nPola, WICOP series, and others. It provides LED’s such as z-power LED, top view LED, through hole, side view LED …
  • CCP Technologies Ltd (AGX)-製薬・医療分野:企業M&A・提携分析
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd is a biotechnology company that offers molecule drugs. The company develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. It develops DiagnostIQ rapid point-of-care human diagnostic techno …
  • Grupo Aval Acciones y Valores SA:企業の戦略・SWOT・財務情報
    Grupo Aval Acciones y Valores SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones y Valores SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Yakult Honsha Co Ltd (2267):製薬・医療:M&Aディール及び事業提携情報
    Summary Yakult Honsha Co Ltd (Yakult) is a probiotics company that undertakes the development, manufacture and commercialization of probiotic and pharmaceutical products. The company’s product portfolio encompasses food and beverages such as fermented milk drinks, juice and others products; pharmace …
  • Nexira:企業の戦略・SWOT・財務情報
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Janus Henderson Group Plc:企業の戦略・SWOT・財務情報
    Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report Summary Janus Henderson Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hamon Research-Cottrell Inc:企業の戦略的SWOT分析
    Hamon Research-Cottrell Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • Aevi Genomic Medicine Inc (GNMX):医療機器:M&Aディール及び事業提携情報
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆